Search clinical trials for: ESR1,
Total 18 results
-
Institut de Cancérologie de LorraineCompleted
-
Fudan UniversityUnknown
-
Herbert LyerlyRecruiting
-
Shannon PuhallaActive, not recruitingMetastatic Breast CancerUnited States
-
Centre Henri BecquerelCompleted
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
University of Wisconsin, MadisonRecruitingERα+ Breast Cancer | ESR1 Gene MutationUnited States
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Centro di Riferimento Oncologico - AvianoRecruitingBreast Neoplasms | Breast Diseases | Antineoplastic Agents | Aromatase Inhibitors | Neoplasms, Breast | Hormone Receptor Positive Breast Carcinoma | ESR1 Gene MutationItaly
-
National Taiwan University HospitalNovartisUnknownMetastatic Breast CancerTaiwan
-
National Taiwan University HospitalUnknownBreast CancerTaiwan
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Finland, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, India, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Gua... and more
-
Mediclinic Middle EastUnknownBreast Cancer FemaleUnited Arab Emirates
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
Sermonix Pharmaceuticals Inc.RecruitingMetastatic Breast CancerUnited States, France, Belgium, Spain, Israel, Taiwan, United Kingdom, Korea, Republic of, Italy, Australia, Germany, Canada, Czechia, Hungary, Poland, Romania, Singapore, Turkey
-
Thomas Jefferson UniversityContext Therapeutics Inc.Active, not recruitingRefractory Endometrial Carcinoma | Refractory Endometrial Endometrioid Adenocarcinoma | Refractory Endometrial Adenocarcinoma | Refractory Endometrial Clear Cell Adenocarcinoma | Refractory Endometrial Mixed Cell Adenocarcinoma | Refractory Endometrial Serous Adenocarcinoma | Refractory Endometrial...United States